Rwanda Food and Drugs Authority (FDA) has banned both Misoprostol and Oxytocin, two types of drugs used to prevent postpartum haemorrhage after finding out that they were substandard.
The drugs entered the country between 2017 and June 2018 from India and China.
According to FDA’s statement, the decision was taken after a joint investigation by FDA, University of Rwanda (UR) and Tübingen University from Germany indicated that the drugs did not meet the minimum substandard.
“FDA is asking all those who prescribe the drugs to keep them in the store and stop spreading but quarantine them. All public and private hospitals, health centers, clinics and pharmacies are asked to stop prescribing the suspicious drugs until the investigation is over,” the statement read.
FDA’s acting director, Charles Karangwa said, “We stopped using the drugs and spreading them.”
According to Christophe Bazivamo, the EAC deputy Secretary General, “about 70% of medicines used in Africa are manufactured in countries where there is no real monitoring system.”
The World Health Organization (WHO) indicates that excessive postpartum haemorrhage may result in death in one hour but injection of standard oxytocin can save her life.
According to figures of the United Nations Population Fund (UNFPA) Post-partum hemorrhage, eclampsia and pre-eclampsia, sepsis, obstructed labour, and post-abortion care account for more than 90% of all maternal deaths around the world,